Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer Article

Xia, Shu, Kohli, Manish, Du, Meijun et al. (2015). Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer . 6(18), 16411-16421. 10.18632/oncotarget.3845

Open Access International Collaboration

cited authors

  • Xia, Shu; Kohli, Manish; Du, Meijun; Dittmar, Rachel L; Lee, Adam; Nandy, Debashis; Yuan, Tiezheng; Guo, Yongchen; Wang, Yuan; Tschannen, Michael R; Worthey, Elizabeth; Jacob, Howard; See, William; Kilari, Deepak; Wang, Xuexia; Hovey, Raymond L; Huang, Chiang-Ching; Wang, Liang

sustainable development goals

authors

publication date

  • June 30, 2015

keywords

  • ANDROGEN RECEPTOR
  • CASTRATION
  • CELLS
  • CIRCULATING TUMOR DNA
  • Cell Biology
  • DOCETAXEL RESISTANCE
  • LIQUID BIOPSY
  • Life Sciences & Biomedicine
  • Oncology
  • PROGRESSION
  • PROTEIN-KINASE
  • PTEN
  • Science & Technology
  • THERAPY
  • cell free DNA
  • liquid biopsy
  • next generation sequencing
  • plasma
  • prostate cancer

Digital Object Identifier (DOI)

publisher

  • IMPACT JOURNALS LLC

start page

  • 16411

end page

  • 16421

volume

  • 6

issue

  • 18